EMIGH JAMES F

VP, Corporate Development at ACURA PHARMACEUTICALS, INC · on record since Dec 19, 2011

Insider trading activity of EMIGH JAMES F

Transactions on record: 40; since May 23, 2008

Open-market buys: 8; $53K

Open-market sells: 0

Companies traded: 1; last filing Feb 26, 2021

Figures computed from official regulatory filings — .

Companies where EMIGH JAMES F has traded

ACURA PHARMACEUTICALS, INC40 tx · $107.6K · Feb 26, 2021

Track record of EMIGH JAMES F

Statistical track record

Free account

Open-market buys: 8

Last buy: Dec 14, 2017

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of EMIGH JAMES F

Co-insiders of EMIGH JAMES F

Abuse Deterrent Pharma, LLCACURA PHARMACEUTICALS, INC
Azad DavidACURA PHARMACEUTICALS, INC
Boehm GarthACURA PHARMACEUTICALS, INC
Brzeczko Albert WACURA PHARMACEUTICALS, INC
CARE CAPITAL II LLCACURA PHARMACEUTICALS, INC
CARE CAPITAL INVESTMENTS II LPACURA PHARMACEUTICALS, INC
Care Capital Offshore Investments II LPACURA PHARMACEUTICALS, INC
CLAUDIUS LLCACURA PHARMACEUTICALS, INC
CLEMENS PETER AACURA PHARMACEUTICALS, INC
ESSEX WOODLANDS HEALTH VENTURES FUND V LLCACURA PHARMACEUTICALS, INC
ESSEX WOODLANDS HEALTH VENTURES FUND V LPACURA PHARMACEUTICALS, INC
GALEN EMPLOYEE FUND III LPACURA PHARMACEUTICALS, INC
Galen Management, LLCACURA PHARMACEUTICALS, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Other	-7,550	0.40 USD	$3K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Exercise	20,000	0.15 USD	$3K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	ExerciseD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Exercise	24,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	4,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Other	-7,402	0.21 USD	$1.6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	ExerciseD (derivative)	4,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Exercise	4,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	60,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 18, 2017	Buy	400,000	0.10 USD	$40K	conv 90ClusterUnusual size+1	SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 11, 2017	AwardD (derivative)	14,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 10, 2017	AwardD (derivative)	14,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2016	AwardD (derivative)	14,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 14, 2015	AwardD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2014	AwardD (derivative)	54,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 27, 2014	ExerciseD (derivative)	-6,225	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 27, 2014	Exercise	6,225	1.30 USD	$8.1K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 13, 2013	AwardD (derivative)	37,500	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	May 6, 2013	ExerciseD (derivative)	-6,225	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	May 6, 2013	Exercise	6,225	1.30 USD	$8.1K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 3, 2013	Other	-6,596	2.22 USD	$14.6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2012	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 30, 2012	Exercise	6,225	1.30 USD	$8.1K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Other	-7,550	0.40 USD	$3K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Exercise	20,000	0.15 USD	$3K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	ExerciseD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Exercise	24,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	4,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Other	-7,402	0.21 USD	$1.6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	ExerciseD (derivative)	4,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Exercise	4,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	60,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 18, 2017	Buy	400,000	0.10 USD	$40K	conv 90ClusterUnusual size+1	SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 11, 2017	AwardD (derivative)	14,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 10, 2017	AwardD (derivative)	14,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2016	AwardD (derivative)	14,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 14, 2015	AwardD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2014	AwardD (derivative)	54,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 27, 2014	ExerciseD (derivative)	-6,225	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 27, 2014	Exercise	6,225	1.30 USD	$8.1K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 13, 2013	AwardD (derivative)	37,500	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	May 6, 2013	ExerciseD (derivative)	-6,225	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	May 6, 2013	Exercise	6,225	1.30 USD	$8.1K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 3, 2013	Other	-6,596	2.22 USD	$14.6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2012	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 30, 2012	Exercise	6,225	1.30 USD	$8.1K		SEC